Vyome Holdings, Inc — Director's Dealing 2017

May 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OBALON THERAPEUTICS INC (OBLN)
CIK: 0001427570
Period of Report: 2017-04-30

Reporting Person: Johnson Steven Ernest (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-30	Common Stock	A	747	$9.03	Acquired	747	Direct

Footnotes

F1: These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).